Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck-Reference-Cited by-同舟云学术

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Published:2016-11-10 Issue:19 Volume:375 Page:1856-1867
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Ferris Robert L.,Blumenschein George,Fayette Jerome,Guigay Joel,Colevas A. Dimitrios,Licitra Lisa,Harrington Kevin,Kasper Stefan,Vokes Everett E.,Even Caroline,Worden Francis,Saba Nabil F.,Iglesias Docampo Lara C.,Haddad Robert,Rordorf Tamara,Kiyota Naomi,Tahara Makoto,Monga Manish,Lynch Mark,Geese William J.,Kopit Justin,Shaw James W.,Gillison Maura L.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1602252

Cited by 3891 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head and neck cancer;Head and Neck Cancer Rehabilitation;2025

2. ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinoma;Gene;2024-12

3. Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders;Oral Oncology;2024-11

4. Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck;Brazilian Journal of Otorhinolaryngology;2024-11

5. PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors;European Journal of Cancer;2024-10